During the past decade, Earle A. Chiles Research Institute at Providence Portland Medical Center conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 2 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 1 clinical trials were completed. i.e. 25% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Earle A. Chiles Research Institute at Providence Portland Medical Center" #1 sponsor was "Dendreon" with 3 trials, followed by "Celgene" with 2 trials sponsored, "Alliance for Clinical Trials in Oncology" with 1 trials sponsored, "Argos Therapeutics" with 1 trials sponsored and "Astellas Pharma Global Development, Inc." with 1 trials sponsored. Other sponsors include 6 different institutions and companies that sponsored additional 16 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Earle A. Chiles Research Institute at Providence Portland Medical Center" #1 collaborator was "National Cancer Institute (NCI)" with 2 trials as a collaborator and "Chiron Corporation" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Earle A. Chiles Research Institute at Providence Portland Medical Center" are "Lymphoma, Non-Hodgkin" (2 trials), "Prostate Cancer" (2 trials), "Advanced Cancer" (1 trials), "Advanced Solid Tumor" (1 trials) and "Bladder Cancer" (1 trials). Many other conditions were trialed in "Earle A. Chiles Research Institute at Providence Portland Medical Center" in a lesser frequency.

Most popular intervention types in "Earle A. Chiles Research Institute at Providence Portland Medical Center" are "Drug" (11 trials), "Biological" (8 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "fluorouracil" (2 trials), "AGS-003" (1 trials), "ALVAC-CEA-B7.1 vaccine" (1 trials) and "APC-Placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Earle A. Chiles Research Institute at Providence Portland Medical Center" are 15 trials for "All" genders, 3 trials for "Male" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Earle A. Chiles Research Institute at Providence Portland Medical Center". undefined are not yet recruiting, 3 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 13 completed trials in Earle A. Chiles Research Institute at Providence Portland Medical Center, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Earle A. Chiles Research Institute at Providence Portland Medical Center, 6 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".